vs
ALERUS FINANCIAL CORP（ALRS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ALERUS FINANCIAL CORP的1.5倍（$69.8M vs $45.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -73.2%，领先457.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 18.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -2.5%）
阿勒鲁斯金融公司（品牌简称Alerus）是一家连锁金融机构，总部位于北达科他州大福克斯，网点分布在北达科他、明尼苏达、威斯康星与亚利桑那州，为客户提供银行、抵押贷款、财富管理以及退休规划等多种金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ALRS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$45.2M
营收增速更快
RIGL
高出3.2%
18.0%
净利率更高
RIGL
高出457.2%
-73.2%
两年增速更快
RIGL
近两年复合增速
-2.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.2M | $69.8M |
| 净利润 | $-33.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -96.0% | 33.2% |
| 净利率 | -73.2% | 384.0% |
| 营收同比 | 18.0% | 21.2% |
| 净利润同比 | -49232.8% | 1769.2% |
| 每股收益（稀释后） | $-1.27 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALRSRIGL
| Q4 25 | $45.2M | $69.8M | ||
| Q3 25 | $72.6M | $69.5M | ||
| Q2 25 | $74.8M | $101.7M | ||
| Q1 25 | $68.8M | $53.3M | ||
| Q4 24 | $72.2M | $57.6M | ||
| Q3 24 | $50.9M | $55.3M | ||
| Q2 24 | $51.4M | $36.8M | ||
| Q1 24 | $47.5M | $29.5M |
净利润ALRSRIGL
| Q4 25 | $-33.1M | $268.1M | ||
| Q3 25 | $16.9M | $27.9M | ||
| Q2 25 | $20.3M | $59.6M | ||
| Q1 25 | $13.3M | $11.4M | ||
| Q4 24 | $-67.0K | $14.3M | ||
| Q3 24 | $5.2M | $12.4M | ||
| Q2 24 | $6.2M | $-1.0M | ||
| Q1 24 | $6.4M | $-8.2M |
毛利率ALRSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ALRSRIGL
| Q4 25 | -96.0% | 33.2% | ||
| Q3 25 | 30.4% | 40.9% | ||
| Q2 25 | 35.2% | 60.1% | ||
| Q1 25 | 25.5% | 23.9% | ||
| Q4 24 | -0.8% | 28.9% | ||
| Q3 24 | 13.4% | 25.4% | ||
| Q2 24 | 15.8% | 1.2% | ||
| Q1 24 | 17.9% | -23.6% |
净利率ALRSRIGL
| Q4 25 | -73.2% | 384.0% | ||
| Q3 25 | 23.3% | 40.2% | ||
| Q2 25 | 27.1% | 58.6% | ||
| Q1 25 | 19.4% | 21.5% | ||
| Q4 24 | -0.2% | 24.9% | ||
| Q3 24 | 10.2% | 22.5% | ||
| Q2 24 | 12.1% | -2.8% | ||
| Q1 24 | 13.5% | -27.9% |
每股收益（稀释后）ALRSRIGL
| Q4 25 | $-1.27 | $14.11 | ||
| Q3 25 | $0.65 | $1.46 | ||
| Q2 25 | $0.78 | $3.28 | ||
| Q1 25 | $0.52 | $0.63 | ||
| Q4 24 | $-0.06 | $0.82 | ||
| Q3 24 | $0.26 | $0.70 | ||
| Q2 24 | $0.31 | $-0.06 | ||
| Q1 24 | $0.32 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.2M | $155.0M |
| 总债务越低越好 | $59.2M | $52.5M |
| 股东权益账面价值 | $564.9M | $391.5M |
| 总资产 | $5.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.10× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ALRSRIGL
| Q4 25 | $67.2M | $155.0M | ||
| Q3 25 | $92.0M | $137.1M | ||
| Q2 25 | $80.9M | $108.4M | ||
| Q1 25 | $83.0M | $77.1M | ||
| Q4 24 | $61.2M | $77.3M | ||
| Q3 24 | $66.0M | $61.1M | ||
| Q2 24 | $438.1M | $49.1M | ||
| Q1 24 | $545.8M | $49.5M |
总债务ALRSRIGL
| Q4 25 | $59.2M | $52.5M | ||
| Q3 25 | $59.2M | $60.0M | ||
| Q2 25 | $59.1M | $60.0M | ||
| Q1 25 | $59.1M | $60.0M | ||
| Q4 24 | $59.1M | $60.0M | ||
| Q3 24 | $59.0M | $60.0M | ||
| Q2 24 | $59.0M | $60.0M | ||
| Q1 24 | $59.0M | $60.0M |
股东权益ALRSRIGL
| Q4 25 | $564.9M | $391.5M | ||
| Q3 25 | $550.7M | $117.6M | ||
| Q2 25 | $533.2M | $81.9M | ||
| Q1 25 | $514.2M | $18.6M | ||
| Q4 24 | $495.4M | $3.3M | ||
| Q3 24 | $386.5M | $-14.6M | ||
| Q2 24 | $373.2M | $-29.9M | ||
| Q1 24 | $371.6M | $-31.7M |
总资产ALRSRIGL
| Q4 25 | $5.2B | $513.6M | ||
| Q3 25 | $5.3B | $242.5M | ||
| Q2 25 | $5.3B | $206.7M | ||
| Q1 25 | $5.3B | $176.0M | ||
| Q4 24 | $5.3B | $164.0M | ||
| Q3 24 | $4.4B | $139.4M | ||
| Q2 24 | $4.4B | $128.4M | ||
| Q1 24 | $4.3B | $126.5M |
负债/权益比ALRSRIGL
| Q4 25 | 0.10× | 0.13× | ||
| Q3 25 | 0.11× | 0.51× | ||
| Q2 25 | 0.11× | 0.73× | ||
| Q1 25 | 0.11× | 3.23× | ||
| Q4 24 | 0.12× | 18.25× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $58.8M | — |
| 自由现金流率自由现金流/营收 | 130.2% | — |
| 资本支出强度资本支出/营收 | 19.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $102.4M | — |
8季度趋势，按日历期对齐
经营现金流ALRSRIGL
| Q4 25 | $67.5M | $22.0M | ||
| Q3 25 | $32.8M | $24.0M | ||
| Q2 25 | $10.7M | $30.5M | ||
| Q1 25 | $7.7M | $-893.0K | ||
| Q4 24 | $21.7M | $14.5M | ||
| Q3 24 | $20.2M | $21.7M | ||
| Q2 24 | $-12.5M | $302.0K | ||
| Q1 24 | $11.7M | $-5.0M |
自由现金流ALRSRIGL
| Q4 25 | $58.8M | — | ||
| Q3 25 | $30.3M | — | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $5.7M | — | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $17.4M | — | ||
| Q2 24 | $-16.1M | — | ||
| Q1 24 | $10.8M | — |
自由现金流率ALRSRIGL
| Q4 25 | 130.2% | — | ||
| Q3 25 | 41.8% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 8.2% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 34.2% | — | ||
| Q2 24 | -31.4% | — | ||
| Q1 24 | 22.8% | — |
资本支出强度ALRSRIGL
| Q4 25 | 19.3% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 1.9% | — |
现金转化率ALRSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.94× | 0.86× | ||
| Q2 25 | 0.53× | 0.51× | ||
| Q1 25 | 0.58× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.88× | 1.75× | ||
| Q2 24 | -2.01× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALRS
| Other | $17.3M | 38% |
| Retirement And Benefit Services | $17.3M | 38% |
| Wealth Management | $7.4M | 16% |
| Mortgage Banking | $3.2M | 7% |
RIGL
暂无分部数据
